Rouan Sarah Kathryn 4
4 · Viking Therapeutics, Inc. · Filed Apr 2, 2025
Insider Transaction Report
Form 4
Rouan Sarah Kathryn
Director
Transactions
- Purchase
Common Stock, par value $0.00001 per share
2025-03-31$24.15/sh+1,240$29,943→ 1,240 total
4 · Viking Therapeutics, Inc. · Filed Apr 2, 2025
Common Stock, par value $0.00001 per share